Akero Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- June 25, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $65,000,000
Company Info
- Company Description
- Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
- Market
- Metabolic diseases
- Location
- Cambridge, MA, USA
- Coinvestors
- Apple Tree Partners, Atlas Venture, VenBio, Versant Ventures